About iMedX
iMedX is a company based in Atlanta (United States) founded in 2002 by Venkat Sharma was acquired by Rapid Care in June 2023. iMedX has raised $22.28 million across 5 funding rounds from investors including Ventureast, RFE Investment Partners and Rapid Care. iMedX has completed 6 acquisitions, including Axcension, G2N and MedWrite. iMedX operates in a competitive market with competitors including Centivo, Xifin, Infinx, Omega Healthcare and AKASA, among others.
- Headquarter Atlanta, United States
- Founders Venkat Sharma
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Imedx Information Services Private Limited
- Date of Incorporation 22 Feb, 2005
- Jurisdiction Amberpet, Telangana, India
-
Annual Revenue
$3.14 M (USD)-25.69as on Mar 31, 2022
-
Net Profit
-$32.18 K (USD)-110.68as on Mar 31, 2022
-
EBITDA
$61.96 K (USD)-83.55as on Mar 31, 2022
-
Total Equity Funding
$22.28 M (USD)
in 5 rounds
-
Latest Funding Round
$4.03 M (USD), Series B
Dec 24, 2013
-
Investors
Ventureast
& 2 more
-
Employee Count
Not available
-
Investments & Acquisitions
Axcension
& 5 more
-
Acquired by
Rapid Care
(Jun 01, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of iMedX
Unlock access to complete
Unlock access to complete
Funding Insights of iMedX
iMedX has successfully raised a total of $22.28M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $4.03 million completed in December 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in iMedX
iMedX has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Ventureast, RFE Investment Partners and Rapid Care.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are managed from the United States.
|
Locked | Locked | Locked | |
|
Venture capital investments in technology, healthcare, and clean environment sectors since 1997.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for iMedX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by iMedX
iMedX has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Axcension, G2N and MedWrite.
Investment portfolio details for iMedX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Limited information is available on G2N's core activities.
|
Locked | Locked | 2015 | Locked | |
|
Vendor risk management solution provider
|
Locked | Locked | 2004 | Locked | |
|
Web-based applications and services are developed and delivered.
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for iMedX
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - iMedX
Detailed financials for iMedX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Imedx Comparisons
Peer comparison for iMedX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of iMedX
iMedX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Centivo, Xifin, Infinx, Omega Healthcare and AKASA, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of self funded health plan
|
|
| Locked | Locked | Locked |
Cloud-based billing & revenue cycle management solutions for diagnostic service providers
|
|
| Locked | Locked | Locked |
Revenue cycle management platform for healthcare is provided.
|
|
| Locked | Locked | Locked |
Healthcare outsourcing services are provided to various sectors.
|
|
| Locked | Locked | Locked |
Revenue cycle automation platforms are provided for healthcare reimbursement.
|
Detailed competitors of iMedX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Imedx
Complete news archive for iMedX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about iMedX
iMedX was founded in 2002 and raised its 1st funding round 7 years after it was founded.
iMedX is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
iMedX is a funded company, having raised a total of $22.28M across 5 funding rounds to date.
Annual revenue of iMedX is $3.14M as on Mar 31, 2022.
iMedX was founded in 2002 in Atlanta, United States, and operates in the healthcare sector. A web and mobile-based platform is offered for revenue cycle management to hospitals and providers. Medical transcription and coding services are included among the solutions. Acquisitions such as G2N, Abacus Transcriptions, Medwrite, Superior Global Solutions, and National Medical Transcription have been completed. The 2015 ACG Atlanta Georgia Fast 40 award was received.
iMedX's top competitors include R1 RCM, Centivo and Access Healthcare.
iMedX has 3 investors. Key investors include Ventureast, RFE Investment Partners, and Rapid Care.